Bill & Melinda Gates Foundation Activity Q4 2020-Q3 2023

Q3 2023
 Value Shares↓ Weighting
BCEL SellATRECA INC$237,287
-74.0%
912,642
-2.1%
0.28%
-61.1%
Q2 2023
 Value Shares↓ Weighting
VIR NewVIR BIOTECHNOLOGY INC$38,245,7531,559,14230.44%
IMCR NewIMMUNCORE HLDGS PLCads$34,592,303576,92327.53%
CVAC NewCUREVAC N V$16,942,3261,625,94313.48%
BNTX NewBIONTECH SEsponsored ads$16,046,385148,67412.77%
NewEXSCIENTIAads$9,418,1811,590,9097.50%
NewLUMIRADX LTD$6,857,14314,285,7145.46%
BFLY NewBUTTERFLY NETWORK INC$2,325,3071,011,0031.85%
BCEL NewATRECA INC$913,179931,8150.73%
AMRS NewAMYRIS INC$301,170292,3980.24%
Q4 2022
 Value Shares↓ Weighting
ZY ExitZYMERGEN INC$0-59,970-0.16%
AMRS ExitAMYRIS INC$0-292,398-0.71%
BCEL ExitATRECA INC$0-1,320,880-1.66%
BFLY ExitBUTTERFLY NETWORK INC$0-1,011,003-3.79%
ExitEXSCIENTIAads$0-1,590,909-10.36%
CVAC ExitCUREVAC N V$0-1,709,781-10.67%
ExitLUMIRADX LTD$0-14,285,714-11.54%
BNTX ExitBIONTECH SEsponsored ads$0-148,674-15.89%
IMCR ExitIMMUNCORE HLDGS PLCads$0-576,923-21.42%
VIR ExitVIR BIOTECHNOLOGY INC$0-1,559,142-23.79%
Q3 2022
 Value Shares↓ Weighting
NewLUMIRADX LTD$14,600,00014,285,71411.54%
BCEL SellATRECA INC$2,100,000
-12.5%
1,320,880
-0.8%
1.66%
-10.0%
Q2 2022
 Value Shares↓ Weighting
VIR NewVIR BIOTECHNOLOGY INC$39,700,0001,559,14230.52%
CVAC NewCUREVAC N V$23,300,0001,709,78117.91%
BNTX NewBIONTECH SEsponsored ads$22,200,000148,67417.06%
IMCR NewIMMUNCORE HLDGS PLCads$21,500,000576,92316.53%
NewEXSCIENTIAads$17,300,0001,590,90913.30%
BFLY NewBUTTERFLY NETWORK INC$3,100,0001,011,0032.38%
BCEL NewATRECA INC$2,400,0001,331,3581.84%
AMRS NewAMYRIS INC$500,000292,3980.38%
ZY NewZYMERGEN INC$100,00059,9700.08%
Q4 2021
 Value Shares↓ Weighting
ZY ExitZYMERGEN INC$0-59,970-0.23%
AMRS ExitAMYRIS INC$0-292,398-1.17%
ExitSERA PROGNOSTICS INC$0-779,814-2.55%
BCEL ExitATRECA INC$0-1,396,644-2.55%
BFLY ExitBUTTERFLY NETWORK INC$0-1,011,003-3.10%
IMCR ExitIMMUNCORE HLDGS PLCads$0-576,923-6.26%
VIR ExitVIR BIOTECHNOLOGY INC$0-677,777-8.64%
BNTX ExitBIONTECH SEsponsored ads$0-148,674-11.88%
ExitLUMIRADX LIMITED$0-5,574,059-13.50%
CVAC ExitCUREVAC N V$0-3,134,780-50.12%
Q3 2021
 Value Shares↓ Weighting
NewLUMIRADX LIMITED$46,100,0005,574,05913.50%
BNTX SellBIONTECH SEsponsored ads$40,600,000
-82.6%
148,674
-85.7%
11.88%
-66.8%
VIR SellVIR BIOTECHNOLOGY INC$29,500,000
-77.5%
677,777
-75.6%
8.64%
-57.1%
NewSERA PROGNOSTICS INC$8,700,000779,8142.55%
Q2 2021
 Value Shares↓ Weighting
BNTX NewBIONTECH SEsponsored ads$233,000,0001,038,67435.80%
CVAC NewCUREVAC N V$230,000,0003,134,78035.34%
VIR NewVIR BIOTECHNOLOGY INC$131,000,0002,777,77720.13%
IMCR NewIMMUNCORE HLDGS PLCads$23,000,000576,9233.53%
BFLY NewBUTTERFLY NETWORK INC$15,000,0001,011,0032.30%
BCEL NewATRECA INC$12,000,0001,396,6441.84%
AMRS NewAMYRIS INC$4,800,000292,3980.74%
ZY NewZYMERGEN INC$2,000,00059,9700.31%

Compare quarters

Export Bill & Melinda Gates Foundation's holdings